Emerald Health Pharmaceuticals Inc.

États‑Unis d’Amérique

 
Quantité totale PI 14
Rang # Quantité totale PI 109 376
Note d'activité PI 1,7/5.0    8
Rang # Activité PI 115 800

Brevets

Marques

7 0
3 0
4 0
0
 
Dernier brevet 2023 - Composition and method for the t...
Premier brevet 2010 - Cannabinoid quinone derivatives

Derniers inventions, produits et services

2021 Invention Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity. Cannabidiol quino...
Invention Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal ...
2020 Invention Formulations of cannabidiol derivatives and their use as modulators of cannabinoid receptor type ...
Invention 2). Compositions, comprising the cannabidiol derivatives of Formula (I) in pharmaceutical formula...
2019 Invention Cannabigerol quinone acid and salts thereof. A compound of formula I A compound of formula I ...
Invention Cannabigerol quinone acid and salts thereof. The application relates to a compound of formula (I)...
2017 Invention Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity. Cannabidiol quinol...
2015 Invention Cannabigerol derivatives. The present invention relates to novel cannabigerol quinone derivatives...
2014 Invention Cannabidiol quinone derivatives. The present invention relates to novel cannabidiol quinone deriv...
2010 Invention Cannabinoid quinone derivatives. Cannabinoid quinone derivatives. The present invention refers to...